FindTrial
Sign In

The feasibility study of keratoconus DNA screening before corneal refractive surgery

The feasibility study of keratoconus DNA screening before corneal refractive surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-SOC-17013818
Enrollment
Unknown
Registered
2017-12-14
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ametropia,corneal refractive surgery

Interventions

corneal refractive surgery :corneal refractive surgery

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Group 1: the Slitlamp Biomicroscopy and corneal topographic examination were diagnosed as keratoconus patients; Group 2: before corneal refractive surgery, the corneal topographic map is suspected to be keratoconus; Group 3: patients older than 40 years, without keratoconus.

Exclusion criteria

Exclusion criteria: 1. Other ophthalmopathy, such as cataract, glaucoma, etc.; 2. Systemic diseases such as asthma and heart disease.

Design outcomes

Primary

MeasureTime frame
keratoconus gene;—

Secondary

MeasureTime frame
corneal topography;Slitlamp Biomicroscopy;Anterior Corneal OCT;—

Countries

China

Contacts

Public ContactZhang Fengju

Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing Tongren Hospital

zhangfj126@126.com+86 18601287753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026